Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00321958 · ClinicalTrials.gov registry record
Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
A clinical trial, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- 23
- Enrollment target
NCT00321958 is a clinical trial that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 23 participants.
The verdict
NCT00321958 was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm the effectiveness and safety of a new medical device which sprays liquid nitrogen through an upper endoscope (cryotherapy) to treat Barrett's esophagus with high-grade dysplasia and early esophageal cancer. It is hypothesized that this treatment will remove the abnormal lining of the esophagus and allow the normal esophageal lining to return.
Interventions
- DEVICE CSA System (CryoSpray AblationTM System)
- DEVICE CryoSpray Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00321958
The ClinicalTrials.gov registry entry for NCT00321958 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CSA System (CryoSpray AblationTM System) is the first listed.
NCT00321958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00321958 about?
NCT00321958 is a clinical study titled "Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer". The purpose of this study is to confirm the effectiveness and safety of a new medical device which sprays liquid nitrogen through an upper endoscope (cryotherapy) to treat Barrett's esophagus with high-grade dysplasia and early esophageal cancer. It is hypothesized that this treatment will remove th...
What is the current status of trial NCT00321958?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2006-04. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00321958?
The interventions under investigation include: CSA System (CryoSpray AblationTM System) (DEVICE), CryoSpray Ablation (DEVICE).
Who is sponsoring clinical trial NCT00321958?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.